A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice-Reference-Cited by-同舟云学术

A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice

Published:2023-09 Issue: Volume:165 Page:115158
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Kaewin Suchada,Poolsri Wanangkan^ORCID,Korkut Gül Gizem,Patrakka Jaakko,Aiebchun Thitinan,Rungrotmongkol Thanyada,Sungkaworn Titiwat,Sukanadi I.Butu,Chavasiri Warinthorn,Muanprasat Chatchai

Funder

Mahidol University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference64 articles.

1. Novel avenues for drug discovery in diabetic kidney disease;Breyer;Expert Opin. Drug Discov.,2018

2. Diabetic nephropathy: landmark clinical trials and tribulations;Chan;Nephrol. Dial. Transplant.,2016

3. The next generation of therapeutics for chronic kidney disease;Breyer;Nat. Rev. Drug Discov.,2016

4. Diabetic kidney disease;Thomas;Nat. Rev. Dis. Prim.,2015

5. The pathogenesis of diabetic nephropathy;Dronavalli;Nat. Clin. Pr. Endocrinol. Metab.,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation;European Journal of Medicinal Chemistry;2024-09

2. FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1;Open Medicine;2024-01-01

3. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects;Biomedicine & Pharmacotherapy;2023-12